{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:04:59Z","timestamp":1775059499519,"version":"3.50.1"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T00:00:00Z","timestamp":1541980800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HD 36071"],"award-info":[{"award-number":["HD 36071"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"DOI":"10.3389\/fgene.2018.00531","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T00:00:46Z","timestamp":1541980846000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["The Spectrum of Neurological and White Matter Changes and Premutation Status Categories of Older Male Carriers of the FMR1 Alleles Are Linked to Genetic (CGG and FMR1 mRNA) and Cellular Stress (AMPK) Markers"],"prefix":"10.3389","volume":"9","author":[{"given":"Danuta Z.","family":"Loesch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Trost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minh Q.","family":"Bui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleanor","family":"Hammersley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sui T.","family":"Lay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah J.","family":"Annesley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oana","family":"Sanislav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire Y.","family":"Allan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flora","family":"Tassone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin R. W.","family":"Ngoei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce E.","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Francis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsdon","family":"Storey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1242\/dmm.025684","article-title":"Immortalized Parkinson\u2019s Disease lymphocytes have enhanced mitochondrial respiratory activity.","volume":"9","author":"Annesley","year":"2016","journal-title":"Dis. Models Mech."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1212\/WNL.0b013e318271f7ff","article-title":"FXTAS: new insights and the need for revised diagnostic criteria.","volume":"79","author":"Apartis","year":"2012","journal-title":"Neurology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.neurobiolaging.2012.12.001","article-title":"Brain structure in asymptomatic FMR1 premutation carriers at risk for fragile X-associated tremor\/ataxia syndrome.","volume":"34","author":"Battistella","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2017.11.001","article-title":"Potential pathogenic mechanisms underlying Fragile X Tremor Ataxia Syndrome: RAN translation and\/or RNA gain-of-function?","author":"Boivin","year":"2017","journal-title":"Eur. J. Med. Genet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1091\/mbc.e06-09-0881","article-title":"Diverse cytopathologies in mitochondrial disease are caused by AMP-activated protein kinase signalling.","volume":"18","author":"Bokko","year":"2007","journal-title":"Mol. Biol. Cell."},{"key":"B6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jns.2015.03.031","article-title":"Fragile X premutation carriers: a systematic review of neuroimaging findings.","volume":"352","author":"Brown","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"B7","first-page":"1757","article-title":"Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction.","volume":"23","author":"Brunberg","year":"2002","journal-title":"Am. J. Neuroradiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1212\/01.wnl.0000239837.57475.3a","article-title":"Molecular and imaging correlates of the fragile X-associated tremor\/ataxia syndrome.","volume":"67","author":"Cohen","year":"2006","journal-title":"Neurology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s12311-016-0809-6","article-title":"Clinical phenotype of adult fragile x gray zone allele carriers: a case series.","volume":"15","author":"Debrey","year":"2016","journal-title":"Cerebellum"},{"key":"B10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.bbadis.2014.12.012","article-title":"Mitochondrial dysfunction in primary human fibroblasts triggers an adaptive cell survival program that requires AMPK-\u03b1.","volume":"1852","author":"Distelmaier","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"B11","first-page":"153","author":"Fahn","year":"1987","journal-title":"Recent Developments in Parkinsons Disease, Unified Parkinson\u2019s Disease Rating Scale."},{"key":"B12","first-page":"225","article-title":"Clinical rating scale for tremor","author":"Fahn","year":"1993","journal-title":"Parkinson\u2019s Disease and Movement Disorders"},{"key":"B13","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.jclinepi.2014.03.012","article-title":"False discovery rate control is a recommended alternative to bonferroni-type adjustments in health studies.","volume":"67","author":"Glickman","year":"2014","journal-title":"J. Clin. Epidemiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/brain\/awh683","article-title":"Neuropathology of fragile X-associated tremor\/ataxia syndrome (FXTAS).","volume":"129","author":"Greco","year":"2006","journal-title":"Brain"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/1866-1955-6-28","article-title":"The cognitive neuropsychological phenotype of carriers of the FMR1 premutation.","volume":"6","author":"Grigsby","year":"2014","journal-title":"J. Neurodev. Disord."},{"key":"B16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/ncpneuro0373","article-title":"Fragile X-associated tremor\/ataxia syndrome\u2013an older face of the fragile X gene.","volume":"3","author":"Hagerman","year":"2007","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S1474-4422(13)70125-X","article-title":"Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor\/ataxia syndrome.","volume":"12","author":"Hagerman","year":"2013","journal-title":"Lancet Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nrneurol.2016.82","article-title":"Fragile X-associated tremor\/ataxia syndrome \u2013 features, mechanisms and management.","volume":"12","author":"Hagerman","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ceb.2014.09.004","article-title":"AMPK: positive and negative regulation, and its role in whole-body energy homeostasis.","volume":"33","author":"Hardie","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: a nutrient and energy sensor that maintains energy homeostasis.","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/brain\/awq368","article-title":"A voxel-based morphometry study of grey matter loss in fragile X-associated tremor\/ataxia syndrome.","volume":"134","author":"Hashimoto","year":"2011","journal-title":"Brain"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.533","article-title":"Calcineurin suppresses AMPK-dependent cytoprotective autophagy in cardiomyocytes under oxidative stress.","volume":"5","author":"He","year":"2014","journal-title":"Cell Death Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/emboj.2009.8","article-title":"TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cells.","volume":"28","author":"Herrero-Mart\u0131n","year":"2009","journal-title":"EMBO J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1093\/hmg\/ddr101","article-title":"CGG-repeat length threshold for FMR1 RNA pathogenesis in a cellular model for FXTAS.","volume":"20","author":"Hoem","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1001\/jama.291.4.460","article-title":"Penetrance of the fragile X-associated tremor\/ataxia syndrome in a premutation carrier population.","volume":"291","author":"Jacquemont","year":"2004","journal-title":"JAMA"},{"key":"B26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jocn.2015.08.010","article-title":"Fragile X-associated tremor\/ataxia syndrome: an under-recognised cause of tremor and ataxia.","volume":"23","author":"Kalus","year":"2016","journal-title":"J. Clin. Neurosci."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8166-1-5","article-title":"An improved diagnostic PCR assay for identification of cryptic heterozygosity for CGG Triplet Repeat Alleles in the Fragile X Gene (FMR1).","volume":"1","author":"Khaniani","year":"2008","journal-title":"Mol. Cytogenet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1093\/hmg\/ddm293","article-title":"An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals.","volume":"16","author":"Ladd","year":"2007","journal-title":"Hum. Mol. Genet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1212\/01.wnl.0000281692.98200.f5","article-title":"FMR1 CGG repeat length predicts motor dysfunction in premutation carriers.","volume":"70","author":"Leehey","year":"2008","journal-title":"Neurology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00401-014-1286-y","article-title":"C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS\/FTD.","volume":"128","author":"Liu","year":"2014","journal-title":"Acta Neuropathol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000446803","article-title":"Novel blood biomarkers are associated with white matter lesions in Fragile X-Associated Tremor\/Ataxia syndrome.","volume":"17","author":"Loesch","year":"2017","journal-title":"Neurodegener. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1136\/jmg.2006.043950","article-title":"Transcript levels of intermediate size or grey zone fragile X mental retardation 1 alleles are raised, and correlate with the number of CGG repeats.","volume":"44","author":"Loesch","year":"2007","journal-title":"J. Med. Genet"},{"key":"B33","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1399-0004.2005.00425.x","article-title":"Evidence for, and a spectrum of, neurological involvement in carriers of the fragile X pre-mutation: FXTAS and beyond.","volume":"67","author":"Loesch","year":"","journal-title":"Clin. Genet."},{"key":"B34","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/ana.20542","article-title":"Magnetic resonance imaging study in older fragile X premutation male carriers.","volume":"58","author":"Loesch","year":"","journal-title":"Ann. Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1002\/ajmg.a.32990","article-title":"Linking the FMR1 alleles with small CGG expansions with neurodevelopmental disorders: preliminary data suggest an involvement of epigenetic mechanisms.","author":"Loesch","year":"","journal-title":"Am. J. Med. Genet. A"},{"key":"B36","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1399-0004.2009.01275.x","article-title":"Small CGG repeat expansion alleles of FMR1 gene are associated with parkinsonism.","volume":"76","author":"Loesch","year":"","journal-title":"Clin. Genet."},{"key":"B37","first-page":"78","article-title":"Unstable mutations in the FMR1 gene and the phenotypes","author":"Loesch","year":"2011","journal-title":"Tandem Repeat Polymorphisms: Genetic Plasticity, Neural Diversity and Disease"},{"key":"B38","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ajmg.b.31189","article-title":"White matter changes in basis pontis in small expansion FMR1 allele carriers with parkinsonism.","volume":"156","author":"Loesch","year":"2011","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"B39","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/cge.12070","article-title":"New evidence for, and challenges in, linking small CGG repeat expansion FMR1 alleles with Parkinson\u2019s disease.","volume":"84","author":"Loesch","year":"2013","journal-title":"Clin. Genet."},{"key":"B40","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/WCO.0000000000000130","article-title":"C9orf72 amyotrophic lateral sclerosis and frontotemporal dementia: gain or loss of function?","volume":"27","author":"Mizielinska","year":"2014","journal-title":"Curr. Opin. Neurol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1093\/hmg\/ddr211","article-title":"Altered zinc transport disrupts mitochondrial protein processing\/import in fragile X-associated tremor\/ataxia syndrome.","volume":"20","author":"Napoli","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-016-0289-4","article-title":"Retention of hexanucleotide repeat-containing intron in C9or72 mRNA: implications for the pathogenesis of ALS\/FTD.","volume":"4","author":"Niblock","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"B43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.expneurol.2017.08.013","article-title":"AMPK activation: role in the signaling pathways of neuroinflammation and neurodegeneration.","author":"Peixoto","year":"2017","journal-title":"Exp. Neurol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/mds.870090114","article-title":"Interrater reliability of the Unified Parkinson\u2019s Disease Rating Scale motor examination.","volume":"9","author":"Richards","year":"1994","journal-title":"Mov. Disord."},{"key":"B45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-1-4419-5805-1_4","article-title":"Radiological findings in FXTAS","author":"Rivera","year":"2010","journal-title":"The Fragile X-Associated Tremor Ataxia Syndrome (FXTAS)"},{"key":"B46","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1042\/BJ20091960","article-title":"Evidence of mitochondrial dysfunction in fragile X-associated tremor\/ataxia syndrome.","volume":"429","author":"Ross-Inta","year":"2010","journal-title":"Biochem. J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0022-510X(93)90041-V","article-title":"A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging.","volume":"114","author":"Scheltens","year":"1993","journal-title":"J. Neurol. Sci."},{"key":"B48","author":"Smith","year":"1982","journal-title":"Symbol Digit Modalities Test."},{"key":"B49","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/mds.21412","article-title":"Assessment of interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor.","volume":"22","author":"Stacy","year":"2007","journal-title":"Mov. Disord."},{"key":"B50","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1074\/jbc.271.2.611","article-title":"Mammalian AMP-activated protein kinase subfamily.","volume":"271","author":"Stapleton","year":"1996","journal-title":"J. Biol. Chem."},{"key":"B51","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/mds.10657","article-title":"Inter-rater reliability of the International Cooperative Ataxia Rating Scale (ICARS).","volume":"19","author":"Storey","year":"2004","journal-title":"Mov. Disord."},{"key":"B52","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/(SICI)1096-8628(19990528)84:3<240::AID-AJMG15>3.0.CO;2-B","article-title":"Strong similarities of the FMR1 mutation in multiple tissues: postmortem studies of a male with a full mutation and a male carrier of a premutation.","volume":"84","author":"Tassone","year":"1999","journal-title":"Am. J. Med. Genet."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2003.012518","article-title":"Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor\/ataxia syndrome.","volume":"41","author":"Tassone","year":"2004","journal-title":"J. Med. Genet."},{"key":"B54","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1086\/302720","article-title":"Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome.","volume":"66","author":"Tassone","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"B55","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.neuron.2013.03.026","article-title":"CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome.","volume":"78","author":"Todd","year":"2013","journal-title":"Neuron"},{"key":"B56","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000356190","article-title":"White matter changes in patients with parkinson\u2019s disease carrying small CGG Expansion FMR1 Alleles: a pilot study.","volume":"14","author":"Trost","year":"2014","journal-title":"Neurodegener. Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0022-510X(96)00231-6","article-title":"International cooperative ataxia rating scale for pharmacological assessment of the cerebellar syndrome. the ataxia neuropharmacology committee of the world federation of neurology.","volume":"145","author":"Trouillas","year":"1997","journal-title":"J. Neurol. Sci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1007\/s00415-008-0874-y","article-title":"Alzheimer\u2019s Disease Cooperative Study Group: periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia.","volume":"255","author":"van Straaten","year":"2008","journal-title":"J. Neurol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1161\/01.STR.32.6.1318","article-title":"A new rating scale for age-related white matter changes applicable to MRI and CT.","volume":"32","author":"Wahlund","year":"2001","journal-title":"Stroke"},{"key":"B60","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1001\/archneurol.2011.2023","article-title":"Age-dependent structural connectivity effects in fragile X premutation.","volume":"69","author":"Wang","year":"2012","journal-title":"Arch. Neurol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/mds.25473","article-title":"A multimodal imaging analysis of subcortical gray matter in fragile X premutation carriers.","volume":"28","author":"Wang","year":"","journal-title":"Mov. Disord."},{"key":"B62","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.neuroimage.2012.09.075","article-title":"Influence of the fragile X mental retardation (FMR1) gene on the brain and working memory in men with normal FMR1 alleles.","volume":"65","author":"Wang","year":"","journal-title":"Neuroimage"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1001\/jamaneurol.2013.2934","article-title":"Fragile X\u2013associated tremor\/ataxia syndrome: influence of the fmr1 gene on motor fiber tracts in males with normal and premutation alleles.","volume":"70","author":"Wang","year":"","journal-title":"JAMA Neurol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2017.03.018","article-title":"Abnormal trajectories in cerebellum and brainstem volumes in carriers of the fragile X premutation.","volume":"55","author":"Wang","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"B65","author":"Wechsler","year":"1997","journal-title":"The Wechsler Adult Intelligence Scale"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.bbagen.2013.10.034","article-title":"Role of AMPK-mediated adaptive responses in human cells with mitochondrial dysfunction to oxidative stress.","volume":"1840","author":"Wu","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B67","doi-asserted-by":"publisher","first-page":"112477","DOI":"10.18632\/oncotarget.22055","article-title":"Activation of AMPK by OSU53 protects spinal cord neurons from oxidative stress.","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fgene.2018.00531\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T08:16:56Z","timestamp":1542010616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fgene.2018.00531\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,12]]},"references-count":67,"alternative-id":["10.3389\/fgene.2018.00531"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2018.00531","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,12]]},"article-number":"531"}}